Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Walter

Showing results (661-670 of 737) with videos related to

Pageof 74
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2019
Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II StudyAndrew H Wei, Stephen A Strickland, Jing-Zhou Hou, et al.
Vaccine|December 17, 2023
Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adultsLisa A Jackson, Jack T Stapleton, Emmanuel B Walter, et al.
JAMA|October 8, 2014
Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trialRobert B Belshe, Sharon E Frey, Irene L Graham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemiaMarina Y Konopleva, Roland B Walter, Stefan H Faderl, et al.
Blood Advances|June 20, 2023
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AMLAnna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, et al.
Blood|June 18, 2013
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AMLMay S Kung Sutherland, Roland B Walter, Scott C Jeffrey, et al.
Genome Biology and Evolution|October 7, 2017
The Novel Evolution of the Sperm Whale GenomeWesley C Warren, Lukas Kuderna, Alana Alexander, et al.
Molecular Cancer Therapeutics|November 17, 2017
Characterization of SGN-CD123A, A Potent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid LeukemiaFu Li, May Kung Sutherland, Changpu Yu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody ResponsesKathleen M Neuzil, Evan J Anderson, Robert W Frenck, et al.
The Lancet. Infectious Diseases|December 16, 2022
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trialEphraim L Tsalik, Nadine G Rouphael, Ruxana T Sadikot, et al.
Pageof 74

Showing results (661-670 of 737) with videos related to

Sort By:
Pageof 74
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2019
Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II StudyAndrew H Wei, Stephen A Strickland, Jing-Zhou Hou, et al.
Vaccine|December 17, 2023
Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adultsLisa A Jackson, Jack T Stapleton, Emmanuel B Walter, et al.
JAMA|October 8, 2014
Immunogenicity of avian influenza A/Anhui/01/2005(H5N1) vaccine with MF59 adjuvant: a randomized clinical trialRobert B Belshe, Sharon E Frey, Irene L Graham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemiaMarina Y Konopleva, Roland B Walter, Stefan H Faderl, et al.
Blood Advances|June 20, 2023
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AMLAnna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, et al.
Blood|June 18, 2013
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AMLMay S Kung Sutherland, Roland B Walter, Scott C Jeffrey, et al.
Genome Biology and Evolution|October 7, 2017
The Novel Evolution of the Sperm Whale GenomeWesley C Warren, Lukas Kuderna, Alana Alexander, et al.
Molecular Cancer Therapeutics|November 17, 2017
Characterization of SGN-CD123A, A Potent CD123-Directed Antibody-Drug Conjugate for Acute Myeloid LeukemiaFu Li, May Kung Sutherland, Changpu Yu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2023
Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody ResponsesKathleen M Neuzil, Evan J Anderson, Robert W Frenck, et al.
The Lancet. Infectious Diseases|December 16, 2022
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trialEphraim L Tsalik, Nadine G Rouphael, Ruxana T Sadikot, et al.
Pageof 74